* Miromatrix Medical Inc MIRO.OQ reported a quarterly
adjusted
loss of 33 cents per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 39 cents per share.
* Revenue rose 11,525% to $930.00 thousand from a year ago;
analysts expected $3.50 thousand.
* Miromatrix Medical Inc's reported EPS for the quarter was
a loss
of 33 cents.
* The mean earnings estimate of analysts had risen by
about 12.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Miromatrix Medical Inc shares had fallen by 50.2% this
quarter.
* The company reported a quarterly loss of $6.95 million.
* Wall Street's median 12-month price target for Miromatrix
Medical Inc is $13.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
March 31 at 09:01 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.39 -0.33 Beat
Sep. 30 2022 -0.40 -0.37 Beat
Jun. 30 2022 -0.33 -0.40 Missed
Mar. 31 2022 -0.29 -0.35 Missed